THYROID CANCER
Clinical trials for THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER trials appear
Sign up with your email to follow new studies for THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough cancers
Disease control TerminatedThis early-stage study tested a new drug called SO-C101, either alone or with another drug (pembrolizumab), in 115 people with advanced solid tumors like lung, kidney, or skin cancer. The main goal was to check safety and find the right dose. The study was stopped early, so resul…
Matched conditions: THYROID CANCER
Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Promising new scan spots thyroid cancer return better?
Diagnosis TerminatedThis study tested a new type of PET scan (68Ga-MY6349) to see if it could find thyroid cancer that has come back or spread. It involved 149 adults with different types of thyroid cancer. The goal was to compare this new scan with the standard 18F-FDG PET/CT to see which one detec…
Matched conditions: THYROID CANCER
Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated May 14, 2026 12:05 UTC
-
New ultrasound technique aims to sharpen cancer detection, but study stalls
Diagnosis TerminatedThis study tested a new, high-speed 3D ultrasound method called acoustic angiography to improve imaging of breast and thyroid cancers. It planned to enroll 45 people, including healthy volunteers and patients scheduled for biopsies. The goal was to see if this technique could bet…
Matched conditions: THYROID CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Diagnosis
Last updated May 11, 2026 20:38 UTC